Pharma Focus Asia Blog
271 FOLLOWERS
Covers articles related to manufacturing, clinical trials, research and development, strategy, Information technology. Pharma Focus Asia, published by Ochre Media, is the leading pharma title in print and digital versions serving the information needs of key executives from the worlds leading pharmaceutical companies.
Pharma Focus Asia Blog
22h ago
BeiGene has received approval from the European Commission for TEVIMBRA tislelizumab in combination with chemotherapy as a firstline treatment for advanced or metastatic oesophageal squamous cell carcinoma ESCC and gastric or gastroesophageal junction GGEJ adenocarcinoma ..read more
Pharma Focus Asia Blog
22h ago
Silo Pharma has entered a joint development agreement with Kymanox to advance the SP ketamineloaded implant SP is a ketaminebased dissolvable polymer implant developed by Silo Pharma for managing chronic pain and fibromyalgia ..read more
Pharma Focus Asia Blog
22h ago
Everest Medicines today announced NEFECONs inclusion in Chinas National Reimbursement Drug List NRDL effective from January NEFECON is a patented oral delayedrelease formulation of budesonide a corticosteroid specifically designed to target the distal ileum ..read more
Pharma Focus Asia Blog
22h ago
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology cardiovascular and metabolic autoimmune ..read more
Pharma Focus Asia Blog
22h ago
Zai Lab Limitedtoday announced that the National Reimbursement Drug List NRDL released by Chinas National Healthcare Security Administration NHSA has been updated to include the following medicines and indications ..read more
Pharma Focus Asia Blog
22h ago
Sichuan KelunBiotech Biopharmaceutical Co Ltdannounced that the Company received marketing authorization in China from National Medical Products Administration NMPA for the first domestically developed trophoblast cellsurface antigen ..read more
Pharma Focus Asia Blog
22h ago
Dr Reddys Laboratories Ltd announced the launch of Toripalimab in India Toripalimab is a New Biological Entity NBE It is the only immunooncology drug approved by various regulatory authorities around the world such as the United States Food and Drug Administration USFDA European Medicines Agency EMA ..read more
Pharma Focus Asia Blog
22h ago
Allink Biotherapeutics a clinicalstage biotechnology company pioneering nextgeneration bispecific antibody and antibodydrug conjugate ADC therapeutics today announced the successful completion of a million Series A financing ..read more
Pharma Focus Asia Blog
22h ago
Zyme Biotech a leading provider of strategic solutions for the biopharmaceutical and life sciences industries proudly announces a groundbreaking partnership with ValGenesis EMEA BV a subsidiary of ValGenesis Inc ..read more
Pharma Focus Asia Blog
1w ago
Celltrion has announced plans to acquire iQone Healthcare Switzerland The acquisition is anticipated to be finalised by the fourth quarter of Following the completion of the transaction iQone Healthcare Switzerland will operate as a whollyowned subsidiary of Celltrion Healthcare Hungary Kft ..read more